Brainsway announces Optum Behavioral expanded policy applicable to Deep TMS

BrainsWay (BWAY) announced that Optum Behavioral Health, a part of UnitedHealth (UNH), has expanded its medical policy applicable to Deep TMS therapy to include coverage for adolescents aged 15 and older with a confirmed diagnosis of major depressive disorder, MDD. “Optum’s policy expansion marks an important step forward in expanding access to a more effective, clinically proven, and non-drug treatment option for young people affected by MDD,” said Hadar Levy, Chief Executive Officer of BrainsWay. “Deep TMS has already changed the trajectory of care for adults facing depression, and extending access to younger patients reflects a shared commitment to early intervention, innovation, and meaningful clinical impact.”